De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

被引：1
|
作者：
Fotiou, Despina [1 ]
Skalioti, Chrysanthi [2 ]
Liapis, George [3 ]
Marinaki, Smaragdi [2 ]
Kastritis, Efstathios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Clin Nephrol & Renal Transplantat, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Dept Pathol, Athens, Greece
来源：
HEMASPHERE | 2021年 / 5卷 / 12期
关键词：
DARATUMUMAB;
D O I：
10.1097/HS9.0000000000000665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody
    Regidor, Bernard Sean
    Siddiqi, Dilawer
    Beatty, Bethany Marie
    Goldwater, Marissa-Skye
    Jew, Scott
    Bujarski, Sean
    Swift, Regina
    Kim, Susanna
    Berenson, James R. R.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (02) : 222 - 223
  • [22] Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies
    Caroni, Federico
    Sammartano, Vincenzo
    Pacelli, Paola
    Sicuranza, Anna
    Malchiodi, Margherita
    Dragomir, Andreea
    Ciofini, Sara
    Raspadori, Donatella
    Bocchia, Monica
    Gozzetti, Alessandro
    PHARMACEUTICALS, 2025, 18 (02)
  • [23] Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies
    Ochoa, Sebastian
    Ding, Li
    Kreuzburg, Samantha
    Treat, Jennifer
    Holland, Steven M.
    Zerbe, Christa S.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2206 - 2208
  • [24] Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
    Lee, Hyun Tae
    Kim, Yujin
    Park, Ui Beom
    Jeong, Tae Jun
    Lee, Sang Hyung
    Heo, Yong-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 536 : 26 - 31
  • [25] Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
    Chiarenza, Decimo Silvio
    Mancini, Raul
    Bigatti, Carolina
    Caridi, Gianluca
    Consolaro, Alessandro
    Natoli, Valentina
    Mortari, Gabriele
    Kajana, Xhuliana
    Lugani, Francesca
    Gattorno, Marco
    Ghiggeri, Gian Marco
    La Porta, Edoardo
    Gaggero, Gabriele
    Verrina, Enrico E.
    Angeletti, Andrea
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [26] Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients
    Suzuki, Kazuhito
    Gunji, Tadahiro
    Nagao, Riku
    Kawashima, Masaharu
    Uryu, Hideki
    Momoki, Mamiko
    Ishii, Hiroto
    Fukushima, Ryoko
    Katori, Mitsuji
    Yokoyama, Hiroki
    Katsube, Atsushi
    Saito, Takeshi
    Nishiwaki, Kaichi
    Yano, Shingo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, : 801 - 812
  • [27] Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review
    Bigi, Flavia
    Manzato, Enrica
    Barbato, Simona
    Talarico, Marco
    Puppi, Michele
    Masci, Simone
    Sacchetti, Ilaria
    Restuccia, Roberta
    Iezza, Miriam
    Rizzello, Ilaria
    Sartor, Chiara
    Mancuso, Katia
    Pantani, Lucia
    Tacchetti, Paola
    Cavo, Michele
    Zamagni, Elena
    PHARMACEUTICALS, 2024, 17 (07)
  • [28] Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma
    Lee, Wendy W. L.
    Lim, Jing Quan
    Tang, Tiffany P. L.
    Tan, Daryl
    Koh, Ser Mei
    Puan, Kia Joo
    Wang, Liang Wei
    Lim, Jackwee
    Tan, Kim Peng
    Chng, Wee Joo
    Lim, Soon Thye
    Ong, Choon Kiat
    Rotzschke, Olaf
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases
    Ziogas, Dimitrios C.
    Terpos, Evangelos
    Gavriatopoulou, Maria
    Migkou, Magdalini
    Fotiou, Despoina
    Roussou, Maria
    Kanellias, Nikolaos
    Tatouli, Ioanna
    Eleutherakis-Papaiakovou, Evangelos
    Panagiotidis, Ioannis
    Ntanasis-Stathopoulos, Ioannis
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 983 - 987
  • [30] Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution
    Matsunaga, Naohiro
    Suzuki, Tomotaka
    Nishitarumizu, Nozomi
    Nakanishi, Yoko
    Kondo, Aki
    Kato, Yukiyasu
    Ebina, Toru
    Marumo, Yoshiaki
    Nakamura, Tomoyuki
    Nakashima, Takahiro
    Kinoshita, Shiori
    Narita, Tomoko
    Ri, Masaki
    Kusumoto, Shigeru
    Komatsu, Hirokazu
    Iida, Shinsuke
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (08) : 531 - 536.e1
12345